FITC anti-human CD45RA [HI100]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0480730
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $90.30
About this award
BioLegend Inc. has been awarded a contract by the University of Virginia for the procurement of laboratory reagents. The contract, designated A207_PO-0480730, was awarded on September 16, 2026, with a cumulative contract value of $90.00. The prime contractor will deliver one unit of FITC anti-human CD45RA [HI100], a fluorescein isothiocyanate-conjugated monoclonal antibody used for flow cytometry applications, to Kara L Cummings at the University of Virginia in Virginia.
This single-line-item purchase order reflects a specialized procurement of immunological reagents for research or diagnostic purposes. The unit price of $90.30 represents a straightforward transactional engagement with no indication of a multi-year performance period or additional deliverable phases. As a Virginia-based contracting action through a state educational institution, this award falls within the University of Virginia's direct procurement authority for research materials and supplies.
Line items
| Item | Total |
|---|---|
| FITC anti-human CD45RA [HI100] | $90.30 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0480730?
Contract A207_PO-0480730 was awarded to BIOLEGEND INC. by University of Virginia on September 16, 2026.
How much is contract A207_PO-0480730 worth?
Its cumulative value is $90.30.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award